PMID- 21825282 OWN - NLM STAT- MEDLINE DCOM- 20130516 LR - 20240418 IS - 1745-1701 (Electronic) IS - 0586-7614 (Print) IS - 0586-7614 (Linking) VI - 38 IP - 6 DP - 2012 Nov TI - Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. PG - 1225-33 LID - 10.1093/schbul/sbr098 [doi] AB - BACKGROUND: The "clinical high risk" (CHR) construct was developed to identify individuals at imminent risk of developing psychosis. However, most individuals identified as CHR do not convert to psychosis, and it is unknown whether these nonconverting individuals actually recover from an at-risk state. METHODS: Eighty-four prospectively identified patients meeting CHR criteria, and 58 healthy comparison subjects were followed in a 2-year longitudinal study. Analyses examined rates of conversion, clinical, and functional recovery. Proportional cause-specific hazard models were used to examine the effects of baseline and time-varying predictors on conversion and remission. Trajectories of symptoms and psychosocial functioning measures were compared across outcome groups. RESULTS: Competing risk survival analyses estimated that 30% of CHR subjects convert to psychosis by 2 years, while 36% symptomatically remit and 30% functionally recover by 2 years. Lower levels of negative and mood/anxiety symptoms were related to increased likelihood of both symptomatic and functional recovery. CHR subjects who remitted symptomatically were more similar to healthy controls in terms of both their baseline and longitudinal symptoms and functioning than the other outcome groups. CONCLUSIONS: Nonconverting CHR cases represented a heterogeneous group. Given that nonconverted subjects who remitted symptomatically also presented initially with less severe prodromal symptomatology and showed a distinct normative trajectory of both symptoms and psychosocial functioning over time, it may be possible to refine the CHR criteria to reduce the number of "false positive" cases by eliminating those who present with less severe attenuated positive symptoms or show early improvements in terms of symptoms or functioning. FAU - Schlosser, Danielle A AU - Schlosser DA AD - Department of Psychiatry, University of California, 401 Parnassus Avenue, Box 0984, San Francisco, CA 94143, USA. danielle.schlosser@ucsf.edu FAU - Jacobson, Sarah AU - Jacobson S FAU - Chen, Qiaolin AU - Chen Q FAU - Sugar, Catherine A AU - Sugar CA FAU - Niendam, Tara A AU - Niendam TA FAU - Li, Gang AU - Li G FAU - Bearden, Carrie E AU - Bearden CE FAU - Cannon, Tyrone D AU - Cannon TD LA - eng GR - T32 MH082719-02/MH/NIMH NIH HHS/United States GR - MH65079/MH/NIMH NIH HHS/United States GR - T32 MH089920-02/MH/NIMH NIH HHS/United States GR - T32 MH089920/MH/NIMH NIH HHS/United States GR - P50 MH066286/MH/NIMH NIH HHS/United States GR - K23 MH087708/MH/NIMH NIH HHS/United States GR - T32 MH082719/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110808 PL - United States TA - Schizophr Bull JT - Schizophrenia bulletin JID - 0236760 SB - IM MH - Adolescent MH - Affective Symptoms/epidemiology MH - Anxiety/epidemiology MH - Case-Control Studies MH - Disease Progression MH - Female MH - Humans MH - Longitudinal Studies MH - Male MH - *Prodromal Symptoms MH - Proportional Hazards Models MH - Prospective Studies MH - Psychotic Disorders/*epidemiology MH - Remission, Spontaneous MH - Risk Factors MH - Time Factors MH - Young Adult PMC - PMC3494042 EDAT- 2011/08/10 06:00 MHDA- 2013/05/17 06:00 PMCR- 2013/11/01 CRDT- 2011/08/10 06:00 PHST- 2011/08/10 06:00 [entrez] PHST- 2011/08/10 06:00 [pubmed] PHST- 2013/05/17 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - sbr098 [pii] AID - 10.1093/schbul/sbr098 [doi] PST - ppublish SO - Schizophr Bull. 2012 Nov;38(6):1225-33. doi: 10.1093/schbul/sbr098. Epub 2011 Aug 8.